{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:35:58Z","timestamp":1768912558039,"version":"3.49.0"},"reference-count":42,"publisher":"Center for Academic Publications Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nutr Sci Vitaminol","JNSV","Journal of Nutritional Science and Vitaminology, J Nutr Sci Vitaminol","Journal of Nutritional Science and Vitaminology"],"published-print":{"date-parts":[[2020,4,30]]},"DOI":"10.3177\/jnsv.66.191","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T22:18:45Z","timestamp":1588198725000},"page":"191-199","source":"Crossref","is-referenced-by-count":6,"title":["<i>Coleus forskohlii<\/i> Extract Attenuated the Beneficial Effect of Diet-Treatment on NASH in Mouse Model"],"prefix":"10.3177","volume":"66","author":[{"given":"Sachina","family":"SUZUKI","sequence":"first","affiliation":[{"name":"Department of Food Function and Labeling, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition"},{"name":"Department of Nutrition and Food Science, Ochanomizu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"NISHIJIMA","sequence":"additional","affiliation":[{"name":"Department of Food Function and Labeling, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"SATO","sequence":"additional","affiliation":[{"name":"Department of Food Function and Labeling, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizo","family":"UMEGAKI","sequence":"additional","affiliation":[{"name":"Department of Food Safety and Management, Showa Women\u2019s University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsune","family":"MURATA","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Food Science, Ochanomizu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"CHIBA","sequence":"additional","affiliation":[{"name":"Department of Food Function and Labeling, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1759","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jou J, Choi SS, Diehl AM. 2008. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 28: 370-379.","DOI":"10.1055\/s-0028-1091981"},{"key":"2","unstructured":"2) Anstee QM, Targher G, Day CP. 2013. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10: 330-344."},{"key":"3","unstructured":"3) Ludwig J, Viggiano TR, McGill DB, Oh BJ. 1980. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sheth SG, Gordon FD, Chopra S. 1997. Nonalcoholic steatohepatitis. Ann Intern Med 126: 137-145.","DOI":"10.7326\/0003-4819-126-2-199701150-00008"},{"key":"5","unstructured":"5) Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37: 917-923."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rector RS, Thyfault JP, Wei Y, Ibdah JA. 2008. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14: 185-192.","DOI":"10.3748\/wjg.14.185"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. 2004. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 15: 10-21.","DOI":"10.1016\/j.ejim.2003.12.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) van Hoek B. 2004. Non-alcoholic fatty liver disease: a brief review. Scand J Gastroenterol Suppl 241: 56-59.","DOI":"10.1080\/00855920410011013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nishijima C, Kobayashi E, Sato Y, Chiba T. 2019. A nationwide survey of the attitudes toward the use of dietary supplements among Japanese high-school students. Nutrients 11: pii: E1469.","DOI":"10.3390\/nu11071469"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kobayashi E, Sato Y, Umegaki K, Chiba T. 2017. The prevalence of dietary supplement use among college students: a nationwide survey in Japan. Nutrients 9: pii: E1250.","DOI":"10.3390\/nu9111250"},{"key":"11","unstructured":"11) Kobayashi E, Nishijima C, Sato Y, Umegaki K, Chiba T. 2018. The prevalence of dietary supplement use among elementary, junior high, and high school students: A nationwide survey in Japan. Nutrients 10: pii: E1176."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Chiba T, Sato Y, Nakanishi T, Yokotani K, Suzuki S, Umegaki K. 2014. Inappropriate usage of dietary supplements in patients by miscommunication with physicians in Japan. Nutrients 6: 5392-5404.","DOI":"10.3390\/nu6125392"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. 2016. Trends in dietary supplement use among US adults from 1999-2012. JAMA 316: 1464-1474.","DOI":"10.1001\/jama.2016.14403"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rashrash M, Schommer JC, Brown LM. 2017. Prevalence and predictors of herbal medicine use among adults in the United States. J Patient Exp 4: 108-113.","DOI":"10.1177\/2374373517706612"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Lentjes MA, Welch AA, Keogh RH, Luben RN, Khaw KT. 2015. Opposites don\u2019t attract: high spouse concordance for dietary supplement use in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) cohort study. Public Health Nutr 18: 1060-1066.","DOI":"10.1017\/S1368980014001396"},{"key":"16","unstructured":"16) Metzger H, Lindner E. 1981. The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittelforschung 31: 1248-1250."},{"key":"17","unstructured":"17) Seamon KB, Daly JW. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7: 201-224."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Ammon HP, Muller AB. 1985. Forskolin: from an ayurvedic remedy to a modern agent. Planta Med 51: 473-477.","DOI":"10.1055\/s-2007-969566"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nishijima C, Chiba T, Sato Y, Yamada H, Umegaki K. 2018. Nationwide online survey method to estimate ongoing adverse events caused by supplement use: Application to diarrhea. Shokuhin Eiseigaku Zasshi (J Food Hygienic Soc Jpn) 59: 106-113.","DOI":"10.3358\/shokueishi.59.106"},{"key":"20","unstructured":"20) Allen DO, Ahmed B, Naseer K. 1986. Relationships between cyclic AMP levels and lipolysis in fat cells after isoproterenol and forskolin stimulation. J Pharmacol Exp Ther 238: 659-664."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Okuda H, Morimoto C, Tsujita T. 1992. Relationship between cyclic AMP production and lipolysis induced by forskolin in rat fat cells. J Lipid Res 33: 225-231.","DOI":"10.1016\/S0022-2275(20)41542-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Han LK, Morimoto C, Yu RH, Okuda H. 2005. Effects of Coleus forskohlii on fat storage in ovariectomized rats. Yakugaku Zasshi 125: 449-453.","DOI":"10.1248\/yakushi.125.449"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Godard MP, Johnson BA, Richmond SR. 2005. Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men. Obes Res 13: 1335-1343.","DOI":"10.1038\/oby.2005.162"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A, Milnor P, Magrans T, Bowden R, Ounpraseuth S, Thomas A, Kreider RB. 2005. Effects of Coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J Int Soc Sports Nutr 2: 54-62.","DOI":"10.1186\/1550-2783-2-2-54"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Pittler MH, Schmidt K, Ernst E. 2005. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev 6: 93-111.","DOI":"10.1111\/j.1467-789X.2005.00169.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Nishijima C, Chiba T, Sato Y, Umegaki K. 2019. Nationwide online survey enables the reevaluation of the safety of Coleus forskohlii extract intake based on the adverse event frequencies. Nutrients 11: pii: E866.","DOI":"10.3390\/nu11040866"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Virgona N, Taki Y, Yamada S, Umegaki K. 2013. Dietary Coleus forskohlii extract generates dose-related hepatotoxicity in mice. J Appl Toxicol 33: 924-932.","DOI":"10.1002\/jat.2770"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Virgona N, Yokotani K, Yamazaki Y, Shimura F, Chiba T, Taki Y, Yamada S, Shinozuka K, Murata M, Umegaki K. 2012. Coleus forskohlii extract induces hepatic cytochrome P450 enzymes in mice. Food Chem Toxicol 50: 750-755.","DOI":"10.1016\/j.fct.2011.11.054"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Yokotani K, Chiba T, Sato Y, Taki Y, Yamada S, Shinozuka K, Murata M, Umegaki K. 2012. Hepatic cytochrome P450 mediates interaction between warfarin and Coleus forskohlii extract in vivo and in vitro. J Pharm Pharmacol 64: 1793-1801.","DOI":"10.1111\/j.2042-7158.2012.01563.x"},{"key":"30","unstructured":"30) Virgona N, Taki Y, Umegaki K. 2010. A rapid HPLC with evaporative light scattering method for quantification of forskolin in multi-herbal weight-loss solid oral dosage forms. Pharmazie 65: 322-326."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chiba T, Suzuki S, Sato Y, Itoh T, Umegaki K. 2016. Evaluation of methionine content in a high-fat and choline-deficient diet on body weight gain and the development of non-alcoholic steatohepatitis in mice. PLoS One 11: e0164191.","DOI":"10.1371\/journal.pone.0164191"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Cho J, Lee I, Kim D, Koh Y, Kong J, Lee S, Kang H. 2014. Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL\/6 mice. J Exerc Nutr Biochem 18: 339-346.","DOI":"10.5717\/jenb.2014.18.4.339"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.","DOI":"10.1016\/S0021-9258(18)64849-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Yokotani K, Chiba T, Sato Y, Nakanishi T, Murata M, Umegaki K. 2013. Influence of dietary macronutrients on induction of hepatic drug metabolizing enzymes by Coleus forskohlii extract in mice. J Nutr Sci Vitaminol 59: 37-44.","DOI":"10.3177\/jnsv.59.37"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Umegaki K, Yamazaki Y, Yokotani K, Chiba T, Sato Y, Shimura F. 2014. Induction of fatty liver by Coleus forskohlii extract through enhancement of de novo triglyceride synthesis in mice. Toxicol Rep 1: 787-794.","DOI":"10.1016\/j.toxrep.2014.09.013"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Suzuki S, Sato Y, Umegaki K, Chiba T. 2015. The major cytochrome P450 subtype activities in diet-induced non-alcoholic steatohepatitis mouse model. Endocrinol Metab Syndrome 4: 1000190.","DOI":"10.4172\/2161-1017.1000190"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Guengerich FP. 1995. Influence of nutrients and other dietary materials on cytochrome P-450 enzymes. Am J Clin Nutr 61: 651s-658s.","DOI":"10.1093\/ajcn\/61.3.651S"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Daily EB, Aquilante CL. 2009. Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies. Pharmacogenomics 10: 1489-1510.","DOI":"10.2217\/pgs.09.82"},{"key":"39","unstructured":"39) Komatsu K, Ito K, Nakajima Y, Kanamitsu S, Imaoka S, Funae Y, Green CE, Tyson CA, Shimada N, Sugiyama Y. 2000. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments. Drug Metab Dispos 28: 475-481."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Neuvonen PJ, Niemi M, Backman JT. 2006. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 80: 565-581.","DOI":"10.1016\/j.clpt.2006.09.003"},{"key":"41","unstructured":"41) Jacobsen W, Kuhn B, Soldner A, Kirchner G, Sewing KF, Kollman PA, Benet LZ, Christians U. 2000. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin. Drug Metab Dispos 28: 1369-1378."},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kamohara S, Terasaki Y, Horikoshi I, Sunayama S. 2015. Safety of a Coleus forskohlii formulation in healthy volunteers. Personalized Medicine Universe 4: 63-65.","DOI":"10.1016\/j.pmu.2015.01.001"}],"container-title":["Journal of Nutritional Science and Vitaminology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/66\/2\/66_191\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T23:28:56Z","timestamp":1615505336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnsv\/66\/2\/66_191\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3177\/jnsv.66.191","relation":{},"ISSN":["0301-4800","1881-7742"],"issn-type":[{"value":"0301-4800","type":"print"},{"value":"1881-7742","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]}}}